EMEA (Europe, Middle East and Africa) Viral Vectors and Plasmid DNA Manufacturing Market Report 2017

November 2017 | 116 pages | ID: E7108542C39EN
QYResearch

Abstracts

In this report, the EMEA Viral Vectors and Plasmid DNA Manufacturing market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (), revenue (Million USD), market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Viral Vectors and Plasmid DNA Manufacturing market competition by top manufacturers/players, with Viral Vectors and Plasmid DNA Manufacturing sales volume (), price (), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Aldevron
• Eurogentec
• Richter-Helm
• BioReliance
• Biovian
• Brammer Bio
• Cell and Gene Therapy Catapult
• Cobra Biologics
• FinVector
• FUJIFILM Diosynth Biotechnologies
• Lonza
• MassBiologics
• MolMed
• Oxford BioMedica
• Sanofi (CEPiA, Sanofi Pasteur, Genzyme)
• Spark Therapeutics
• UniQure
• ViGene Biosciences
• Wuxi AppTec

On the basis of product, this report displays the sales volume (), revenue (Million USD), product price (), market share and growth rate of each type, primarily split into

• Plasmid DNA
• Viral Vectors
• Non-Viral Vectors

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (), market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing for each application, including

• Cancers
• Inherited Disorders
• Viral Infections
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Viral Vectors and Plasmid DNA Manufacturing Market Report 2017

1 VIRAL VECTORS AND PLASMID DNA MANUFACTURING OVERVIEW

1.1 Product Overview and Scope of Viral Vectors and Plasmid DNA Manufacturing
1.2 Classification of Viral Vectors and Plasmid DNA Manufacturing
  1.2.1 EMEA Viral Vectors and Plasmid DNA Manufacturing Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Viral Vectors and Plasmid DNA Manufacturing Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Plasmid DNA
  1.2.4 Viral Vectors
  1.2.5 Non-Viral Vectors
1.3 EMEA Viral Vectors and Plasmid DNA Manufacturing Market by Application/End Users
  1.3.1 EMEA Viral Vectors and Plasmid DNA Manufacturing Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Cancers
  1.3.3 Inherited Disorders
  1.3.4 Viral Infections
  1.3.5 Others
1.4 EMEA Viral Vectors and Plasmid DNA Manufacturing Market by Region
  1.4.1 EMEA Viral Vectors and Plasmid DNA Manufacturing Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Viral Vectors and Plasmid DNA Manufacturing (2012-2022)
  1.5.1 EMEA Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)

2 EMEA VIRAL VECTORS AND PLASMID DNA MANUFACTURING COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Viral Vectors and Plasmid DNA Manufacturing Market Competition by Players/Manufacturers
  2.1.1 EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Viral Vectors and Plasmid DNA Manufacturing Sale Price by Players (2012-2017)
2.2 EMEA Viral Vectors and Plasmid DNA Manufacturing (Volume and Value) by Type/Product Category
  2.2.1 EMEA Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Viral Vectors and Plasmid DNA Manufacturing Sale Price by Type (2012-2017)
2.3 EMEA Viral Vectors and Plasmid DNA Manufacturing (Volume) by Application
2.4 EMEA Viral Vectors and Plasmid DNA Manufacturing (Volume and Value) by Region
  2.4.1 EMEA Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Price by Region (2012-2017)

3 EUROPE VIRAL VECTORS AND PLASMID DNA MANUFACTURING (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
  3.1.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
3.2 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type
3.3 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application
3.4 Europe Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales Volume by Countries (2012-2017)
  3.4.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2012-2017)
  3.4.3 Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
  3.4.4 France Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
  3.4.5 UK Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
  3.4.6 Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
  3.4.7 Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

4 MIDDLE EAST VIRAL VECTORS AND PLASMID DNA MANUFACTURING (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
  4.1.1 Middle East Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
4.2 Middle East Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type
4.3 Middle East Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application
4.4 Middle East Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Viral Vectors and Plasmid DNA Manufacturing Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
  4.4.4 Israel Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
  4.4.5 UAE Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
  4.4.6 Iran Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

5 AFRICA VIRAL VECTORS AND PLASMID DNA MANUFACTURING (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
  5.1.1 Africa Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
5.2 Africa Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type
5.3 Africa Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application
5.4 Africa Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Viral Vectors and Plasmid DNA Manufacturing Sales Volume by Countries (2012-2017)
  5.4.2 Africa Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2012-2017)
  5.4.3 South Africa Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)

6 EMEA VIRAL VECTORS AND PLASMID DNA MANUFACTURING MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Aldevron
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Eurogentec
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Richter-Helm
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 BioReliance
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Biovian
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Brammer Bio
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Cell and Gene Therapy Catapult
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Cobra Biologics
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 FinVector
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 FUJIFILM Diosynth Biotechnologies
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Lonza
6.12 MassBiologics
6.13 MolMed
6.14 Oxford BioMedica
6.15 Sanofi (CEPiA, Sanofi Pasteur, Genzyme)
6.16 Spark Therapeutics
6.17 UniQure
6.18 ViGene Biosciences
6.19 Wuxi AppTec

7 VIRAL VECTORS AND PLASMID DNA MANUFACTURING MANUFACTURING COST ANALYSIS

7.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET FORECAST (2017-2022)

11.1 EMEA Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Viral Vectors and Plasmid DNA Manufacturing Price and Trend Forecast (2017-2022)
11.2 EMEA Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Type (2017-2022)
11.7 EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Viral Vectors and Plasmid DNA Manufacturing
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Volume () by Type (2012-2022)
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Volume Market Share by Type (Product Category) in 2016
Figure Plasmid DNA Product Picture
Figure Viral Vectors Product Picture
Figure Non-Viral Vectors Product Picture
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Volume () by Application (2012-2022)
Figure EMEA Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Application in 2016
Figure Cancers Examples
Figure Inherited Disorders Examples
Figure Viral Infections Examples
Figure Others Examples
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Market Size (Million USD) by Region (2012-2022)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Status and Forecast by Countries
Figure Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Volume and Growth Rate (2012-2022)
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Market Major Players Product Sales Volume () (2012-2017)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Volume () of Major Players (2012-2017)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Share by Players (2012-2017)
Figure 2016 Viral Vectors and Plasmid DNA Manufacturing Sales Share by Players
Figure 2017 Viral Vectors and Plasmid DNA Manufacturing Sales Share by Players
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) by Players (2012-2017)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players (2012-2017)
Table 2016 EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players
Table 2017 EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sale Price () by Players (2012-2017)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sales () and Market Share by Type (2012-2017)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Share by Type (2012-2017)
Figure Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Type (2012-2017)
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Type (2012-2017)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Type in 2016
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sale Price () by Type (2012-2017)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sales () and Market Share by Application (2012-2017)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Share by Application (2012-2017)
Figure Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Application (2012-2017)
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application in 2016
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sales () and Market Share by Region (2012-2017)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Share by Region (2012-2017)
Figure Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Region (2012-2017)
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in 2016
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Region (2012-2017)
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share Regions in 2016
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Price () by Region (2012-2017)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales () by Type (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2012-2017)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type in 2016
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales () by Application (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2012-2017)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Application in 2016
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales () by Countries (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Countries (2012-2017)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Countries (2012-2017)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Countries in 2016
Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) by Countries (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2012-2017)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2012-2017)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries in 2016
Figure Germany Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure France Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure UK Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Russia Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Italy Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Benelux Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Middle East Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Middle East Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Viral Vectors and Plasmid DNA Manufacturing Sales () by Type (2012-2017)
Table Middle East Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2012-2017)
Figure Middle East Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2012-2017)
Table Middle East Viral Vectors and Plasmid DNA Manufacturing Sales () by Applications (2012-2017)
Table Middle East Viral Vectors and Plasmid DNA Manufacturing Market Share by Applications (2012-2017)
Figure Middle East Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application in 2016
Table Middle East Viral Vectors and Plasmid DNA Manufacturing Sales Volume () by Countries (2012-2017)
Table Middle East Viral Vectors and Plasmid DNA Manufacturing Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Viral Vectors and Plasmid DNA Manufacturing Sales Volume Market Share by Countries in 2016
Table Middle East Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) by Countries (2012-2017)
Table Middle East Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2012-2017)
Figure Middle East Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2012-2017)
Figure Middle East Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries in 2016
Figure Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Israel Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure UAE Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Iran Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Africa Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Viral Vectors and Plasmid DNA Manufacturing Sales () by Type (2012-2017)
Table Africa Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Type (2012-2017)
Figure Africa Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Type (2012-2017)
Figure Africa Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Type in 2016
Table Africa Viral Vectors and Plasmid DNA Manufacturing Sales () by Application (2012-2017)
Table Africa Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application (2012-2017)
Figure Africa Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application (2012-2017)
Table Africa Viral Vectors and Plasmid DNA Manufacturing Sales Volume () by Countries (2012-2017)
Table Africa Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Countries (2012-2017)
Figure Africa Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Countries (2012-2017)
Figure Africa Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Countries in 2016
Table Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) by Countries (2012-2017)
Table Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2012-2017)
Figure Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries (2012-2017)
Figure Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Countries in 2016
Figure South Africa Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Nigeria Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Egypt Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Algeria Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Table Aldevron Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in EMEA (2012-2017)
Figure Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in EMEA (2012-2017)
Table Eurogentec Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in EMEA (2012-2017)
Figure Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in EMEA (2012-2017)
Table Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in EMEA (2012-2017)
Figure Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in EMEA (2012-2017)
Table BioReliance Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table BioReliance Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure BioReliance Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure BioReliance Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in EMEA (2012-2017)
Figure BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in EMEA (2012-2017)
Table Biovian Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table Biovian Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Biovian Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Biovian Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in EMEA (2012-2017)
Figure Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in EMEA (2012-2017)
Table Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in EMEA (2012-2017)
Figure Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in EMEA (2012-2017)
Table Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in EMEA (2012-2017)
Figure Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in EMEA (2012-2017)
Table Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in EMEA (2012-2017)
Figure Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in EMEA (2012-2017)
Table FinVector Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table FinVector Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure FinVector Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure FinVector Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in EMEA (2012-2017)
Figure FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in EMEA (2012-2017)
Table FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate (2012-2017)
Figure FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales Market Share in EMEA (2012-2017)
Figure FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share in EMEA (2012-2017)
Table Lonza Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table MassBiologics Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table MolMed Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table Sanofi (CEPiA, Sanofi Pasteur, Genzyme) Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table Spark Therapeutics Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table UniQure Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table ViGene Biosciences Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table Wuxi AppTec Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral Vectors and Plasmid DNA Manufacturing
Figure Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing
Figure Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
Table Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Manufacturers in 2016
Table Major Buyers of Viral Vectors and Plasmid DNA Manufacturing
Table Distributors/Traders List
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Sales () and Growth Rate Forecast (2017-2022)
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Price () and Trend Forecast (2017-2022)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sales () Forecast by Region (2017-2022)
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Market Share Forecast by Region (2017-2022)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share Forecast by Region (2017-2022)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales () Forecast by Countries (2017-2022)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Sales Market Share Forecast by Countries (2017-2022)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Viral Vectors and Plasmid DNA Manufacturing Sales () Forecast by Countries (2017-2022)
Figure Middle East Viral Vectors and Plasmid DNA Manufacturing Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Viral Vectors and Plasmid DNA Manufacturing Sales () Forecast by Countries (2017-2022)
Figure Africa Viral Vectors and Plasmid DNA Manufacturing Sales Market Share Forecast by Countries (2017-2022)
Table Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sales () Forecast by Type (2017-2022)
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Market Share Forecast by Type (2017-2022)
Table EMEA Viral Vectors and Plasmid DNA Manufacturing Sales () Forecast by Application (2017-2022)
Figure EMEA Viral Vectors and Plasmid DNA Manufacturing Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources